Cleared Traditional

K896620 - NEUROTENS

K896620 is an FDA 510(k) clearance for NEUROTENS, manufactured by Henley Intl.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 156-day FDA review.

K896620 · Henley Intl. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1990
Decision
156d
Days
Class 2
Risk

K896620 is an FDA 510(k) clearance for the NEUROTENS. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Henley Intl. (Sugar Land, US). The FDA issued a Cleared decision on April 26, 1990 after a review of 156 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K896620

510(k) Number K896620 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 21, 1989
Decision Date April 26, 1990
Days to Decision 156 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
7d slower than avg
Panel avg: 149d · This submission: 156d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K896620.
TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION
K896787 · Saratoga Intl., Inc. · Jul 1990
ACUDATA INDICATENS MODEL 5A
K900596 · Acudata Software · Jun 1990
ACUDATA INDICATENS MODEL 5XS
K900668 · Acudata Software · Jun 1990
LISS BODY STIMULATOR MODEL SBL501-M
K896226 · Medical Consultants Intl. , Ltd. · Apr 1990
ALPHA-STIM CS
K896948 · Electromedical Products, Inc. · Feb 1990
ELECTRO-ACUSCOPE 85
K883911 · Biomedical Design Instruments · Feb 1990
K896620 · NEUROTENS
Download PDF Henley Intl.